{"id":"NCT00996606","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs","officialTitle":"Open Label, Multicentric Phase IIIb Study to Evaluate the Effect of Tocilizumab in Combination With DMARDs in the Inhibition of Progression of Synovitis, Bone Marrow Edema, and Erosions Evaluated by Dedicated Magnetic Resonance Imaging (MRI) in the Hand of Patients With Rheumatoid Arthritis (RA)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10","primaryCompletion":"2012-04","completion":"2012-04","firstPosted":"2009-10-16","resultsPosted":"2016-11-09","lastUpdate":"2017-06-19"},"enrollment":58,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"DMARDs","otherNames":[]},{"type":"DRUG","name":"Tocilizumab","otherNames":["RoActemra, Actemra"]}],"arms":[{"label":"Tocilizumab in Active RA","type":"EXPERIMENTAL"}],"summary":"This open-label, single-arm study will evaluate the efficacy and safety of tocilizumab in combination with DMARDs in participants with moderate to severe active rheumatoid arthritis who have an inadequate response to DMARDs. Participants will receive tocilizumab as 8 milligrams per kilogram (mg/kg) via intravenous (IV) infusion every 4 weeks in addition to their current DMARD therapy.","primaryOutcome":{"measure":"Change From Baseline to Week 4 in Synovitis of the Wrist According to Rheumatoid Arthritis Magnetic Resonance Imaging (RAMRIS) Score","timeFrame":"Baseline and Week 4","effectByArm":[{"arm":"Tocilizumab in Active RA","deltaMin":5.78,"sd":2.72}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":11,"countries":["Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":58},"commonTop":["Hypercholesterolaemia","Neutropenia","Blood triglycerides increased","Nasopharyngitis","Cough"]}}